Family Study of Lymphoproliferative Disorders
Genetic Epidemiology of Lymphoproliferative Disorders
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years to 100 Years
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study looks at how genes and things people are exposed to may play a role in blood and lymph node cancers, such as leukemia and lymphoma. It is for families with at least two living blood relatives who have a lymphoproliferative disorder, a condition in which too many white blood cells grow.
Blood and lymph node cancers can begin in either the lymphatic tissues (as in the case of lymphoma) or in the bone marrow (as with leukemia and myeloma), and they all are involved with the uncontrolled growth of white blood cells. There are many subtypes of these cancers, e.g., chronic lymphocytic leukemia and non-Hodgkin lymphoma. Since there is evidence that these cancers cluster in families, this study aims to understand how genetics and environmental exposures contribute to the development of these cancers.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Your family must have at least two living blood relatives with a condition in which too many white blood cells grow.
Who can't join
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
At least 2 living, blood related relatives, affected with a lymphoproliferative disorder.
Study sites (1)
MN
- Mayo Clinic · Rochester, MN 55905Clinical Trials Referral Office · Study contact · 855-776-0015 · mayocliniccancerstudies@mayo.eduSusan L Slager, PhD · Principal investigatorMore trials in Rochester